VICTORIA, BC, Oct. 15 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation , a pharmaceutical company focused on increasing the pool of evidence-based medicines available for patients living with less common diseases, announced today that the company will release financial and business results for the third quarter ending September 30, 2007 on Wednesday, October 31st.
Aspreva will host a conference call to discuss results for the third quarter 2007 on Wednesday, October 31, 2007 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).
The call will be available for replay until Wednesday, November 7th, by calling 1-888-286-8010 (North America) or 1-617-801-6888 (International) and entering the pass code 79726236.
A live webcast will also be available to all interested parties on Aspreva’s website: www.aspreva.com. Please click on the “Webcasts and Events” link under the Investors section. A replay of the webcast will be available until the Company’s fourth quarter 2007 conference call.
About Aspreva Pharmaceuticals
Aspreva is a global pharmaceutical company focused on identifying, developing, and, upon approval, commercializing evidence-based medicines for patients living with less common diseases. Aspreva common stock is traded on the NASDAQ Global Select Market under the trading symbol “ASPV” and on the Toronto Stock Exchange under the trading symbol “ASV”. Learn more at www.aspreva.com.
CONTACT: Sage Baker, VP, Investor Relations & Corporate Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270, sbaker@aspreva.com
CONTACT: Sage Baker, VP, Investor Relations & Corporate Communications,
Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270, sbaker@aspreva.com
